Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market Size, Growth, Analysis, Trends, and Opportunities | 2018-2027
WiseGuyRerports.com Presents “ Epiomic Epidemiology Series: Non-Alcoholic Fatty Liver Disease (NAFLD) Forecast in 11 Major Markets 2017-2027” New Document to its Studies Database Scope of the Report: The Epidemiology Series Forecast Report on Non-Alcoholic Fatty Liver Disease (NAFLD) in 11 Major Markets Non-alcoholic fatty liver disease (NAFLD) is the presence of hepatic steatosis in the absence of competing liver disease. It is a spectrum of liver disorders associated with steatosis, with no evidence of significant alcohol consumption. NAFLD develops in four main stages; Steatosis (simple fatty liver), Non-alcoholic steatohepatitis (NASH), Fibrosis and Cirrhosis. Non-alcoholic steatohepatitis (NASH) is a more serious form of steatosis, due to the added inflammation. It is defined as the presence of hepatic steatosis and inflammation with hepatocyte injury (ballooning) with or without fibrosis. This can progress to cirrhosis, liver failure and, more rarely, h...